Cleveland Clinic Cancer Advances

With the onset of the global pandemic in early 2020, we were fast tracked into the world of virtual visits in order to continue seeing cancer patients who were hesitant or unable to seek in-person care. James Stevenson, MD, Vice-Chair of the Department of Hematology and Medical Oncology in the Taussig Cancer Institute discusses how virtual visits are transforming the way we deliver cancer care for...

Invasive lobular breast cancer accounts for approximately 10-15% of all invasive breast cancer cases and is the second most commonly diagnosed type of invasive breast cancer. Megan Kruse, MD joins the podcast to discuss ongoing and upcoming research to identify optimal treatment plans and outcomes for patients fighting this disease.

Timothy Chan, MD, Director of our new Center for Immunotherapy and Precision Immuno-Oncology, joins us to discuss his vision to help advance immunotherapy, developmental therapeutics and research at Cleveland Clinic both in Northeast Ohio as well as at our regional sites in Florida, Abu Dhabi and eventually London. Dr. Chan discusses his vision on collaborating and breaking down silos not only int...

Matt Kalaycio, MD, Vice-Chair of the Taussig Cancer Institute joins us to discuss how we’ve adjusted the way we deliver care to cancer patients during a global pandemic. He touches on how we’re protecting our patients and caregivers, how we quickly adapted our cancer center to promote social distancing, appropriate use of PPE and proper screening, the increase use of virtual visits and the importa...

A prototype blood-based screening test evaluated by Cleveland Clinic researchers and other experts can accurately identify the presence and originating site of 12 high-mortality cancer types, across all stages of progression, with a low false-positive rate, according to the latest results of an ongoing national clinical trial. Eric Klein, MD, Chairman of Cleveland Clinic’s Glickman Urological &amp...

Imagine yourself in your patients’ shoes, feeling the anxiety and fear of having just been diagnosed with cancer. Now imagine being told it’s going to take 6 weeks or longer before you’re able to receive treatment. Brian J. Bowell, MD, Chairman of Cleveland Clinic Taussig Cancer Institute, discusses how reducing time to treatment became a vision for him and how he helped inspire our cancer center...